Navigation Links
New Greenline Tea FASTRACK Solves Cold-Flow Issues

Proprietary blend of materials and equipment produces high-performing cold weather biodiesel

SAN FRANCISCO, Feb. 3 /PRNewswire/ -- Greenline Industries, the world's largest producer of small-to-medium scale biodiesel production equipment and a leading provider of clean-tech energy platforms, announces the release of "Greenline Tea FASTRACK", a cold-flow solution that combines a proprietary blend of materials with a new equipment and process to deliver a superior biodiesel product. The patent-pending solution eliminates cold-flow issues, so the resulting biodiesel passes the new mandatory ASTM cold soak test and always performs in cold weather.

"We are excited to be able to provide all biodiesel producers, regardless of equipment brand, a much needed cold-flow solution that is ready now, when the industry needs it," said Donn Tice, CEO of Greenline Industries. "The Greenline Tea FASTRACK system is simple, modular, 'plug-and-play' and extremely cost-effective, with a terrific return on investment. It will enable the world-wide biodiesel industry to once and for all solve one of the major production problems, which has been an obstacle to consistently perfect year-round biodiesel performance and broad-scale adoption."

The Greenline Tea FASTRACK process ensures that biodiesel produced from a vast array of feedstocks will pass the ASTM cold-soak test. B100 (100 percent biodiesel) passed through the Greenline Tea process will remove sterol glucosides, monoglycerides, sulfur and phosphorus with minimal impact on product yield.

"We want to remove any technical barriers to biodiesel adoption; our vision is to make biodiesel accessible anywhere in the world. All of our technologies and processes have been developed to that end," said Jacques Sinoncelli, Co-Founder of Greenline Industries. "With Greenline Tea FASTRACK, we help eliminate concerns that biodiesel content greater than 20 percent could create cold-flow problems."

Greenline Tea provides substantial return on investment with a minimal increase in processing cost. The ability to produce 12 months a year and distribute fuel in all locations, increases revenue by as much as a factor of two, with a minimal increase in production cost. With capital costs less than 10 percent of the overall price of a biodiesel plant, this solution is cost effective and improves profitability.

About Greenline Industries:

With over 35 biodiesel processing lines on four continents, providing our clients with an excess of 250 million gallons of capacity, Greenline Industries is the world leader of proven, EPA award-winning, waterless modular processing technology. With offices in the USA, Brussels, Romania, India, and Argentina, we offer proven expertise, on a global scale. For more information, visit Greenline's Web site at or telephone (415) 526-7600.

    Wendy Smith

SOURCE Greenline Industries
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Memoirs of a qubit: Hybrid memory solves key problem for quantum computing
2. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
3. Massive reanalysis of genome data solves case of the lethal genes
4. Neurosurgery Journal Issues Supplement Dedicated to CyberKnife Radiosurgery Experience
5. ETHEX Corporation Issues Nationwide Voluntary Recall of Products
6. Ther-Rx Corporation Issues Nationwide Voluntary Recall of Products
7. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
8. FDA Issues Complete Response Letter for Iclaprim
9. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
10. Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on The Medical House PLC
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... Md. , Nov. 25, 2015  PharmAthene, Inc. ... Directors has adopted a stockholder rights plan (Rights Plan) ... net operating loss carryforwards (NOLs) under Section 382 of ... --> PharmAthene,s use of its NOLs ... "ownership change" as defined in Section 382 of the ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
Breaking Biology Technology:
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
Breaking Biology News(10 mins):